Anzeige
Mehr »
Dienstag, 07.04.2026 - Börsentäglich über 12.000 News
Diese Entwicklung im KI-Sektor könnte unterschätzt werden - und sie betrifft die Energieversorgung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QPKG | ISIN: US29415V1098 | Ticker-Symbol:
NASDAQ
06.04.26 | 21:57
0,702 US-Dollar
-6,03 % -0,045
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ENVOY MEDICAL INC Chart 1 Jahr
5-Tage-Chart
ENVOY MEDICAL INC 5-Tage-Chart

Aktuelle News zur ENVOY MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiEnvoy Medical, Inc.: Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant198White Bear Lake, Minnesota--(Newsfile Corp. - April 1, 2026) - Envoy Medical, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company pioneering fully implanted hearing solutions, announced...
► Artikel lesen
27.03.Envoy Medical, Inc. - 8-K, Current Report1
ENVOY MEDICAL Aktie jetzt für 0€ handeln
23.03.Envoy Medical GAAP EPS of -$1.23, revenue of $0.02M1
23.03.Envoy Medical, Inc. - 10-K, Annual Report2
23.03.Envoy Medical, Inc.: Envoy Medical Reports Full Year 2025 Financial Results580Received FDA approval to expand fully implanted Acclaim Cochlear Implant Pivotal Clinical Trial to final stageStrengthened balance sheet by extinguishing $32 million in debtSubsequent to year-end...
► Artikel lesen
11.03.Envoy Medical, Inc.: Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant297White Bear Lake, Minnesota--(Newsfile Corp. - March 11, 2026) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing...
► Artikel lesen
11.03.EXCLUSIVE: Envoy Medical Hits Trial Milestone For Cochlear Implant Designed To Work With Natural Ear2
27.02.Envoy Medical, Inc. - 8-K, Current Report1
24.02.Envoy Medical regains compliance with Nasdaq5
24.02.Envoy Medical: Nasdaq-Konformität nach Bilanzstärkung wiederhergestellt6
24.02.Envoy Medical, Inc.: Envoy Medical Regains Compliance with Nasdaq Listing Requirement318White Bear Lake, Minnesota--(Newsfile Corp. - February 24, 2026) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing...
► Artikel lesen
23.02.Envoy Medical receives three new patents for cochlear implant tech4
23.02.Envoy Medical, Inc.: Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space323White Bear Lake, Minnesota--(Newsfile Corp. - February 23, 2026) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing...
► Artikel lesen
19.02.Envoy Medical raises $30 million, nears completion of cochlear implant trial2
19.02.Envoy Medical sichert sich 30 Mio. US-Dollar und treibt klinische Studie für Cochlea-Implantat voran2
19.02.Envoy Medical, Inc.: Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial232Financing was led by new investor and top-tier healthcare fund Nantahala Capital and longtime Envoy Medical shareholder, billionaire Glen Taylor Closing of $30 million in gross proceeds in upsized...
► Artikel lesen
17.02.Envoy Medical, Inc.: Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant224White Bear Lake, Minnesota--(Newsfile Corp. - February 17, 2026) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing...
► Artikel lesen
12.02.Envoy Medical, Inc.: Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering360$30.0 million upfront with up to an additional $48.0 million of potential aggregate gross proceeds upon the exercise in full of milestone-linked warrants for cashOffering led by Nantahala Capital...
► Artikel lesen
11.02.Envoy Medical, Inc. - 8-K, Current Report3
11.02.Envoy Medical announces pricing of up to $78M public offering3
Weiter >>
67 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1